Mouse models of human disease. Part II: Recent progress and future directions

Genes and Development

Volumn 11, Issue 1, 1997, Pages 11-43

  Bedell, Mary A ^a,b   Largaespada, David A ^a,c   Jenkins, Nancy A ^a   Copeland, Neal G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b University of Georgia ^*  (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; BONE MALFORMATION; CANCER GENETICS; CHONDROPATHY; ENDOCRINE DISEASE; GENETIC DISORDER; HEARING DISORDER; HEMATOLOGIC DISEASE; HUMAN; IMMUNOPATHOLOGY; METABOLIC DISORDER; MOUSE; MOUSE STRAIN; NEURAL CREST; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN DISEASE; VISUAL DISORDER;

EID: 0031028759     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.1.11     Document Type: Review

References (353)

1. Adlkofer, K., R. Martini, A. Aguzzi, J. Zielasek, K.V. Toyka, and U. Suter. 1995. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nature Genet. 11: 274-280.
2. Anderson, D.C. and T.A, Springer. 1987. Leukocyte adhesion deficiency: An inherited defect in the Mac-1, LFA-1, and p150,95 glycoprotems. Annu. Rev. Med. 38: 175-194.
3. Andrikopolous, K., X. Liu, D.R. Keene, R. Jaenisch, and F. Ramirez, 1995. Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nature Genet. 9: 31-36.
4. Avraham, K.B., T. Hasson, K.P. Steel, D.M. Kingsley, L.B. Russell, M.S. Mooseker, N.G. Copeland, and N.A. Jenkins, 1995. The mouse Snell's waltzer deafness gene encodes an unconventional myosin required for structural integrity of inner ear hair cells. Nature Genet. 11: 369-375.
5. Baker, S.M., C.E. Bronner, L. Zhang, A.W. Plug, M. Robatzek, G. Warren, E.A. Elliott, J. Yu, T. Ashley, N. Arnheim, R.A. Flavell, and R.M. Liskay. 1995. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 82: 309-319.
6. Baker, S.M., A.W. Plug, T.A. Prolla, C.E. Bronner, A.C. Harris, X. Yao, D.-M. Christie, C. Monell, N. Arnheim, A. Bradley, T. Ashley and R.M. Liskay. 1996. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nature Genet. 13: 336-342.
7. Bakker, C.E., C. Verheij, R. Willemsen, R. Van der Helm, F. Oerlemans, M. Vermey, A. Bygrave, A.T. Hoogeveen, B.A. Oostra, et al. 1994. Fmr1 knockout mice: A model to study fragile X mental retardation. Cell 78: 23-33.
8. Baldwin, C.T., C.F. Hoth, R.A. Macina, and A. Milunsky. 1995. Mutations in PAX3 that cause Waardenburg syndrome type I: Ten new mutations and review of the literature. Am. J. Med. Genet. 58: 115-122.
9. Barbosa, M.D.F.S., Q.A. Nguyen, V.T. Tchernev, J.A. Ashley, J.C. Detter, S.M. Blaydes, S.J. Brandt, D. Chotai, C. Hodgman, R.C.E. Solari, M. Lovett, and S.F. Kingsmore. 1996. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 382: 262-265.
10. Barlow, C., S. Hirotsune, R. Paylor, M. Liyanage, M. Eckhaus, F. Collins, Y. Shiloh, J.N. Crawley, T. Ried, D. Tagle, and A. Wynshaw-Boris. 1996. Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell 86: 159-171.
11. Barrat, F.J., L. Auloge, E. Pastural, R.D. Lagelouse, E. Vilmer, A.J. Cant, J. Weissenbach, D. Le Paslier, A. Fischer, and B. de Saint Basile. 1996. Genetic and physical mapping of the Chediak-Higashi syndrome on chromosome 1q42-43. Am. J. Hum. Genet. 59: 625-632.
12. Barsh, G.S. 1996. The genetics of pigmentation: From fancy genes to complex traits. Trends Genet. 12: 299-305.
13. Baynash, A.G., K. Hosoda, A. Giaid, J.A. Richardson, N. Emoto, R.E. Hammer, and M. Yanagisawa. 1994. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79: 1277-1285.
14. Becker, M.A. and B.J. Roessler. 1995. Hyperuricemia and gout. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 1655-1677. McGraw-Hill, New York, NY.
15. Becker, P.S. and S.E. Lux. 1995. Hereditary spherocytosis and hereditary elliptocytosis. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 3513-3560. McGraw-Hill, New York, NY.
16. Bedell, M.A., N.A. Ienkins, and N.G. Copeland. 1997. Mouse models of human disease. Part I: Techniques and resources for genetic analysis in mice. Genes & Dev. (this issue).
17. Bellus, G.A., I. McIntosh, E.A. Smith, A.S. Aylsworth, I. Kaitila, W.A. Horton, G.A. Greenhaw, J.T. Hecht, and C.A. Francomano. 1995. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nature Genet. 10: 357-359.
18. Bennett, J., T. Tanabe, D. Sun, Y. Zeng, H. Kjeldbye, P. Gouras, and A.M. Maguire. 1996. Photoreceptor cell rescue in retinal degeneration [rd) mice by in vivo gene therapy. Nature Med. 2: 649-654.
19. Berrettini, W.H., T.N. Ferraro, R.C. Alexander, A.M. Buchberg, and W.H. Vogel. 1994. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. Nature Genet. 7: 54-58.
20. Berry, C.L., C. Vogler, N.J. Galvin, E.H. Birkenmeier, and W.S. Sly. 1994. Pathology of the ear in the murine mucopolysaccharidosis type VII. Morphologic correlates of hearing loss. Lab. Invest. 71: 438-445.
21. Besmer, P., K. Manova, R. Duttlinger, E.J. Huang, A. Packer, C. Gyssler, and R.F. Bachvarova. 1993. The kit-ligand (steel factor) and its receptor c-kit/W: Pleiotropic roles in gametogenesis and melanogenesis. Development (Suppl.): 125-137.
22. Bi, L., A.M. Lawler, S.E. Antonarakis, K.A. High, J.D. Gearhart, and H.H. Kazazian, Jr. 1995. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nature Genet. 10: 119-121.
23. Bingham, P.M., M.O. Scott, S. Wang, M.J. McPhaul, E.M. Wilson, J.Y. Garbern, D.E. Merry, and K.H. Fischbeck. 1995. Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice. Nature Genet. 9: 191-196.
24. Bloom, M.L., T.M. Kaysser, C.S. Birkenmeier, and J.E. Barker. 1994. The murine mutation jaundiced is caused by replacement of an arginine with a stop codon in the mRNA encoding the ninth repeat of β-spectrin. Proc. Natl Acad. Sci. 91: 10099-10103.
25. Bomstein, P., C.E. McKinney, M.E. LaMarca, S. Winfield, T. Shingu, S. Devarayalu, H.L. Vos, and E.I. Ginns. 1995. Metaxin, a gene contiguous to both thrombospondin 3 and glucocerebrosidase, is required for embryonic development in the mouse: Implications for Gaucher disease. Proc. Natl. Acad. Sci. 92: 4547-4551.
26. m1Pas) in the house mouse. Genomics 16: 645-648.
27. Bowes, C., T. Li, M. Danciger, L.C. Baxter, M.L. Applebury, and D.B. Farber. 1990. Retinal degeneration in the rd mouse is caused by a defect in the β subunit of rod cGMP-phosphodiesterase. Nature 347: 677-680.
28. Bowes, C., T. Li, W.N. Frankel, M. Danciger, J.M. Coffin, M.L. Applebury, and D.B. Farber. 1993. LocaLization of a retroviral element within the rd gene coding for the β-subunit of cGMP phosphodiesterase. Proc. Natl. Acad. Sci. 90: 2955-2959.
29. Bowman, B.H., L. Jansen, F. Yang, G.S. Adrian, M. Zhao, S.S. Atherton, J.M. Buchanan, R. Greene, C. Walter, D.C. Herbert, F.J. Weaker, L.K. Chiodo, K. Kagan-Hallet, and I.E. Hixson. 1995. Discovery of a brain promoter from the human transferrin gene and its utilization for development of transgenic mice that express human apolipoprotein E alleles. Proc. Natl. Acad. Sci. 92: 12115-12119.
30. Brady, S.T. 1993. Motor neurons and neurofilaments in sickness and in health. Cell 73: 1-3.
31. Brannan, C.I., A.S. Perkins, K.S. Vogel, N. Ratner, M.L. Nordlund, S.W. Reid, A.M. Buchberg, N.A. Jenkins, L.F. Parada, and N.G. Copeland. 1994. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes & Dev. 8: 1019-1029.
32. Breslow, J.L. 1994. Insights into lipoprotein metabolism from studies in transgenic mice. Annu. Rev. Physiol. 56: 797-810.
33. _. 1996. Mouse models of atherosclerosis. Science 272: 685-688.
34. Bronner, C.E., S.M. Baker, P.T. Morrison, G. Warren, L.G. Smith, M.K. Lescoe, M. Kane, C. Earabino, J. Lipford, A. Lindblom, P. Tannergard, R.J. Bollag, A.R. Godwin, D.C. Ward, M. Nordenskjold, R. Fishel, R. Kolodner, and R.M. Liskay. 1994. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368: 258-261.
35. Brown, R.H., Jr. 1995. Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice. Cell 80: 687-692.
36. Brusilow, S.W. and A.L. Horwich. 1995. Urea cycle enzymes. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 1187-1232. McGraw-Hill, New York, NY.
37. Bullard, D.C., K. Scharffetter-Kochanek, M.J. McArthur, J.G. Chosay, M.E. McBride, C.A. Montgomery, and A.L. Beaudet. 1996. A polygenic mouse model of psoriasiform skin disease in CD-18-deficient mice. Proc. Nad. Acad. Sci. 93: 2116-2121.
38. Burright, E.N., H.B. Clark, A. Servadio, T. Manila, R.M. Feddersen, W.S. Yunis, L.A. Duvick, H.Y. Zoghbi, and H.T. Orr. 1995. SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82: 937-948.
39. Campbell, K.P. 1995. Three muscular dystrophies: Loss of cyto-skeleton-extracellular matrix linkage. Cell 80: 675-679.
40. Cannon-Albright, L.A. and M.H. Skolnick. 1996. The genetics of familial breast cancer. Semin. Oncol. 23: 1-5.
41. Chakravarti, A. 1996. Endothelin receptor-mediated signaling in Hirschsprung disease. Hum. Mol. Genet. 5: 303-307.
42. Chapman, V.M., D.R. Miller, D. Armstrong, and C.T. Caskey. 1989. Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc. Natl. Acad. Sci. 86: 1292-1296.
43. Chaudhari, N. 1992. A single nucleotide deletion in the skeletal muscle-specific calcium channel transcript of muscular dysgenesis (mdg) mice. J. biol. Chem. 267: 25636-25639.
44. Chen, Y.T. and A. Burchell. 1995. Glycogen storage diseases. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 935-965. McGraw-Hill, New York, NY.
45. Chipman, S.D., H.O. Sweet, D.J. McBride, Jr., M.T. Davisson, S.C. Marks, Jr., A.R. Shuldiner, R.J. Wenstrup, D.W. Rowe, and J.R. Shapiro. 1993. Defective proα2(I) collagen synthesis in a recessive mutation in mice: A model of human osteogenesis imperfects. Proc. Natl. Acad. Sci. 90: 1701-1705.
46. min-globin genes in embryonic stem cells. Proc. Natl. Acad. Sci. 92: 9259-9263.
47. Clarke, A.R. 1995. Murine models of neoplasia: Functional analysis of the tumour suppressor genes Rb-1 and p53. Cancer Metastasis Rev. 14: 125-148.
48. Collard, J.-F., F. Cote, and J.-P. Julien. 1995. Detective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 375: 61-64.
49. Collinge, J., M.A. Whittington, K.C. Sidle, C.J. Smith, M.S. Palmer, A.R. Clarke, and J.G. Jefferys. 1994. Prion protein is necessary for normal synaptic function. Nature 370: 295-297.
50. Collinge, J., M.S. Palmer, K.C.L. Sidle, A.F. Hill, I. Gowland, J. Meads, E. Asante, R. Bradley, L.J. Doey, and P.L. Lantos. 1995. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature 378: 779-783.
51. Colvin, J.S., B.A. Bohne, G.W. Harding, D.G. McEwen, and D.M. Ornitz. 1996. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nature Genet. 12: 390-397.
52. Cox, G.A., N.M. Cole, K. Matsumura, S.F. Phelps, S.D. Hauschka, K.P. Campbell, J.A. Faulkner, and J.S. Chamberlain. 1993a. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364: 725-728.
53. Cox, G.A., S.F. Phelps, V.M. Chapman, and J.S. Chamberlain. 1993b. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nature Genet. 4: 87-93.
54. Cox, G.A., Y. Sunada, K.P. Campbell, and J.S. Chamberlain. 1994. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nature Genet. 8: 333-339.
55. Crabbe, J.C., J.K. Belknap, and K.J. Buck. 1994. Genetic animal models of alcohol and drug abuse. Science 264: 1715-1723.
56. d'Azzo, A., G. Andria, P. Strisciuglio, and H. Galjaard. 1995. Galactosialidosis. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 2825-2837. McGraw-Hill, New York, NY.
57. Das, S., B. Levinson, C. Vulpe, S. Whitney, J. Gitschier, and S. Packman. 1995. Similar splicing mutations of the Menkes/ Mottled copper-transporting ATPase gene in occipital horn syndrome and the blotchy mouse. Am. J. Hum. Genet. 56: 570-576.
58. Davidson, D.J., J.R. Dorin, G. McLachlan, V. Ranaldi, D. Lamb, C. Doherty, J. Govan, and D.J. Porteous. 1995. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nature Genet. 9: 351-357.
59. Deconinck, N., T. Ragot, G. Maréchal, M. Perricaudet, and J.M. Gillis. 1996. Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc. Natl. Acad. Sci. 93: 3570-3574.
60. Delaney, S.J., E.W.F.W. Alton, S.N. Smith, D.P. Lunn, R. Farley, P.K. Lovelock, S.A. Thomson, D.A. Hume, D. Lamb, D.J. Porteous, J.R. Dorin, and B.J. Wainwright. 1996. Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations. EMBO J. 15: 955-963.
61. Deng, C.-X., A. Wynshaw-Boris, M.M. Shen, C. Daugherty, D.M. Ornitz, and P. Leder. 1994. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes &. Dev. 8: 3045-3057.
62. Deng, C.-X., A. Wynshaw-Boris, F. Zhou, A. Kuo, and P. Leder. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84: 911-921.
63. De Sanctis, G.T., M. Merchant, D.R. Beier, R.D. Dredge, J.K. Grobholz, T.R. Martin, E.S. Lander, and J.M. Drazen. 1995. Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice. Nature Genet. 11: 150-154.
64. de Wind, N., M. Dekker, A. Berns, M. Radman, and H. te Riele, 1995. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyper-recombination, and predisposition to cancer. Cell 82: 321-330.
65. Dietrich, W.F., E.S. Lander, J.S. Smith, A.R. Moser, K.A. Gould, C. Luongo, N. Borenstein, and W. Dove. 1993. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75: 631-639.
66. DiSanto, J.P., W. Müller, D. Guy-Grand, A. Fischer, and K. Rajewsky. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc. Natl. Acad. Sci. 92: 377-381.
67. Dollé, P., A. Dierich, M. LeMeur, T. Schimmang, B. Schuhhaur, P. Chambon, and D. Duhoule. 1993. Disruption of the Hoxd-13 gene induces localized heterochrony leading to mice with neotenic limbs. Cell 75: 431-441.
68. Donis-Keller, H., S. Dou, D. Chi, K.M. Carlson, K. Toshima, T.C. Lairmore, J.R. Howe, J.F. Moley, P. Goodfellow, and S.A. Wells, Jr. 1993. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum. Mol. Genet. 2: 851-856.
69. Dorin, J.R. 1995. Development of mouse models for cystic fibrosis. J. Inher. Metab. Dis. 18: 495-500.
70. Dorin, J.R., P. Dickinson, E.W.F.W. Alton, S.N. Smith, D.M. Geddes, B.J. Stevenson, W.L. Kimber, S. Fleming, A.R. Clarke, M.L. Hooper, L. Anderson, R.S.P. Beddington, and D.J. Porteous. 1992. Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature 359: 211-215.
71. Drumm, M.L. and F.S. Collins. 1993. Molecular biology of cystic fibrosis. Mol Genet. Med. 3: 33-68.
72. Duprez, L., J. Parma, J. Van Sande, A. Allgeier, J. Leclère, C. Schvartz, M.-J. Delisle, M. Decoulx, J. Orgiazzi, J. Dumont, and G. Vassart. 1994. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nature Genet. 7: 396-401.
73. Duverger, N., G. Tremp, J.M. Caillaud, F. Emmanuel, G. Castro, J.C. Fruchart, A. Steinmetz, and P. Denefle. 1996. Protection against atherogenesis in mice mediated by human apolipro-protein A-IV. Science 273: 966-968.
74. Duyao, M.P., A.B. Auerbach, A. Ryan, F. Persichetti, G.T. Barnes, S.M. McNeil, P. Ge, J.-P. Vonsattel, J.F. Gusella, A.L. Joyner, and M.E. MacDonald. 1995. Inactivation of the mouse Huntington's disease gene homolog Hdh, Science 269: 407-410.
75. Eber, S.W., J.M. Gonzalez, M.L. Lux, A.L. Scarpa, W.T. Tse, M. Dornwell, J. Herbers, W. Kugler, R. Ozean, A. Pekrun, P.G. Gallagher, W. Schröter, E.G. Forget, and S.E. Lux. 1996. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nature Genet. 13: 214-218.
76. Edery, P., T. Attié, J. Armel, A. Pelet, C. Eng, R.M.W. Hofstra, H. Martelli, C. Bidaud, A. Munnich, and S. Lyonnet. 1996. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nature Genet. 12: 442-444.
77. Engle, S.J., M.G. Stockelman, J. Chen, G. Boivin, M.-N. Yum, P.M. Davies, M.Y. Ying, A. Sahota, H.A. Simmonds, P.J. Stambrook, and J.A. Tischfield. 1996a. Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis. Proc. Natl. Acad. Sci. 93: 5307-5312.
78. Engle, S.J., D.E. Womer, P.M. Davies, G. Boivin, A. Sahota, H.A. Simmonds, P.J. Stambrook, and J.A. Tischfield. 1996b. HPRT-APRT deficient mice are not a model for Lesch-Nyhan syndrome. Hum. Mol. Genet. 5: 1607-1610.
79. Ezoe, K., S.A. Holmes, L. Ho, C.P. Bennett, J.L. Bolognia, L. Brueton, J. Burn, R. Falabella, E.M. Gatto, N. Ishii, C. Moss, M.R. Pittelkow, E. Thompson, K.A. Ward, and R.A. Spritz. 1995. Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism. Am. J. Hum. Genet. 56: 58-66.
80. Fabry, M.E. 1993, Transgenic animal models of sickle cell disease. Experientia 49: 28-36.
81. Fabry, M.E., A. Sengupta, S.M. Suzuka, F. Costantini, E.M. Rubin, J. Hofrichter, G. Christoph, E. Manci, D. Culberson, S.M. Factor, and R.L. Nagel. 1995. A second generation transgenic mouse model expressing both hemoglobin S (HbS) and Hbs-Antilles results in increased phenotypic severity. Blood 86: 2419-2428.
82. Farese, R.V., Jr., S.L. Ruland, L.M. Flynn, R.P. Stokowski, and S.G. Young. 1995. Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proc. Natl. Acad. Sci. 92: 1774-1778.
83. Farrmgton, M., L.S. Grosmaire, S. Nonoyama, S.H. Fischer, D. Hollenbaugh, J.A. Ledbetter, R.J. Noelle, A. Aruffo, and H.D. Ochs. 1994. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc. Natl. Acad. Sci. 91: 1099-1103.
84. Fässler, R., P.N.J. Schnegelsberg, J. Dausman, T. Shinya, Y. Muragaki, M.T. McCarthy, B.R. Olsen, and R. Jaenisch. 1994. Mice lacking α1(IX) collagen develop noninflammatory degenerative joint disease. Proc. Natl. Acad. Sci. 91: 5070-5074.
85. Figlewicz, D.A., A. Krizus, M.G. Martinoli, V. Meininger, M. Dib, G.A. Rouleau, and J.P. Julien. 1994. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet. 3: 1757-1761.
86. Fishel, R., M.K. Lescoe, M.R.S. Rao, N.G. Copeland, N.A. Jenkins, J. Garber, M. Kane, and R. Kolodner. 1993. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75: 1027-1038.
87. Fisher, G.H., F.J. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middelton, A.Y. Lin, W. Strober, M.J. Lenardo, and J.M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935-946.
88. Fleischman, R.A. 1992. Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene. J. Clin. Invest. 89: 1713-1717.
89. _. 1993. From white spots to stem cells: The role of the Kit receptor in mammalian development. Trends Genet. 9: 285-290.
90. Frankel, W.N. 1995. Taking stock of complex trait genetics in mice. Trends Genet. 11: 471-477.
91. Fuchs, E. 1995. Genetic skin disorders of keratin. In The metabolic and molecular bases of inherited disease. 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 4421-4437. McGraw-Hill, New York, NY.
92. Gal, A., U. Orth, W. Baehr, E. Schwinger, and T. Rosenberg. 1994. Heterozygous missense mutation in the rod cGMP phosphodiesterase β-subunit gene in autosomal dominant stationary night blindness. Nature Genet. 7: 64-68.
93. Gallagher, P.G. and B.C. Forget. 1993. Spectrin genes in health and disease. Semin. Hematol. 30: 4-20.
94. Games, D., D. Adams, R. Alessandrini, R. Harbour, P. Berthelette, C. Blackwell, T. Carr, J. Clemens, T. Donaldson, F. Gillespie, T. Guido, S. Hagoplan, K. Johnson-Wood, K. Khan, M. Lee, P. Leihowitz, I. Lieberburg, S. Little, E. Masliah, L. McConlogue, M. Montoya-Zavala, L. Mucke, L. Paganini, E. Penniman, M. Power, D. Schenk, P. Seubert, B. Snyder, F. Soriano, H. Tan, J. Vitale, S. Wadsworth, B. Wolozin, and J. Zhao. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nuture 373: 523-527.
95. Gaspar, M.-L., T. Meo, P. Bourgarel, J.-L. Guenet, and M. Tosi. 1991. A single base deletion in the Tfm androgen receptor gene creates a short-lived messenger RNA that directs internal translation initiation. Proc. Natl. Acad. Sci. 88: 8606-8610.
96. Gibson, F., J. Walsh, P. Mburu, A. Varela, K.A. Brown, M. Antonio, K.W. Belsel, K.P. Steel, and S.D.M. Brown. 1995. A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 374: 62-64.
97. Glaser, T., L. Jepeal, J.G. Edwards, S.R. Young, J. Favor, and R.L. Maas. 1994. PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia, and central nervous system defects. Nature Genet. 7: 463-471.
98. Godfrey, P., J.O. Rahal, W.G. Beamer, N.G. Copeland, N.A. Jenkins, and K.E. Mayo. 1993. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nature Genet. 4: 227-232.
99. Goldstein, J.L., H.H. Hobbs, and M.S. Brown. 1995. Familial hypercholesterolemia. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 1981-2030. McGraw-Hill, New York, NY.
100. Goodfellow, P.J. 1994. Inherited cancers associated with the RET proto-oncogene. Curr. Opin. Genet. Dev. 4: 446-452.
101. Gowen, L.C., B.L. Johnson, A.M. Latour, K.K. Sulik, and B.H. Koller. 1996. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nature Genet. 12: 191-194.
102. Greenberg, D.S., Y. Sunada, K.P. Campbell, D. Yaffe, and U. Nudel. 1994. Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nature Genet. 8: 340-344.
103. Griffiths, I.R., P. Montague, and P. Dickinson. 1995. The proteolipid protein gene. Neuropathol. Appl. Neurobiol. 21: 85-96.
104. Grimber, G., C. Galand, M. Garbarz, M.G. Mattel, C. Cavard, A. Zider, P. Blanchet, P. Boivin, P. Briand, and D. Dhermy. 1992. Inherited haemolytic anaemia created by insertional inactivation of the alpha-spectrin gene. Transgenic Res. 1: 268-274.
105. Groden, J., A. Thliveris, W. Samowitz, M. Carlson, L. Gelbert, H. Albertsen, G. Joslyn, J. Stevens, L. Spirio, M. Robertson, L. Sargeant, K. Krapcho, E. Wolff, R. Bun, J.P. Hughes, J. Warrington, J. McPherson, J. Wasmuth, D. Le Paslier, H. Abderrahim, D. Cohen, M. Leppert, and R. White. 1991. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589-600.
106. Grompe, M., M. Al-Dhalimy, M. Finegold, C.N. Ou, T. Burlingame, N.G. Kennaway, and P. Soriano. 1993. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes &. Dev. 7: 2298-2307.
107. Gmbh, B.R., R.J. Pickles, H. Ye, J.R. Yankaskas, R.N. Vick, J.F. Engelhardt, J.M. Wilson, L.G. Johnson, and R.C. Boucher. 1994. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371: 802-806.
108. Gutmann, D.H. and F.S. Collins. 1993. The neurofibromatosis type 1 gene and its protein product, neurofibromin. Neuron 10: 335-343.
109. Hakem, R., J.L. de la Pompa, C. Sirard, R. Mo, M. Woo, A. Haken, A. Wakeham, J. Potter, A. Reitmair, F. Billia, E. Firpo, C.C. Hui, J. Roberts, J. Rossant, and T.W. Mak. 1996. The tumor suppressor gene Brcal is required for embryonic cellular proliferation in the mouse. Cell 85: 1009-1023.
110. Hamer, D.H. 1993. "Kinky hair" disease sheds light on copper metabolism. Nature Genet. 3: 3-4.
111. Hanson, I. and V. van Heyningen. 1995. Pax6: More than meets the eye. Trends Genet. 11: 268-272.
112. Hanson, I.M., J.M. Fletcher, T. Jordan, A. Brown, D. Taylor, R.J. Adams, H.H. Punnett, and V. van Heyningen. 1994. Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly. Nature Genet. 6: 168-173.
113. Harper, P.S. 1995. Myotonic dystrophy and other autosomal muscular dystrophies. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 4227-4251. McGraw-Hill, New York, NY.
114. Harvey, M., H. Vogel, D. Morris, A. Bradley, A. Bernstein, and L.A. Donehower. 1995. A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nature Genet. 9: 305-311.
115. Helbling-Leclerc, A., X. Zhang, H. Topaloglu, C. Cruaud, F. Tesson, J. Weissenbach, P.M.S. Tomé, K. Schwartz, M. Fardeau, K. Tryggvason, and P. Guicheney. 1995. Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature Genet. 11: 216-218.
116. Hemminki, A., P. Peltomäki, J.-P. Mecklin, H. Järvinen, R. Salovaara, M. Nyström-Lahti, A. De la Chapelle, and L.A. Aaltonen. 1994. Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nature Genet. 8: 405-410.
117. Henthorn, P.S., M. Raducha, K.N. Fedde, M.A. Lafferty, and M.P. Whyte. 1992. Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. Proc. Natl. Acad. Sci. 89: 9924-9928.
118. Higgins, L.S. and B. Cordell. 1995. Transgenic mice and modeling Alzheimer's disease. Rev. Neurosci. 6: 87-96.
119. Hiltunen, A., M. Metsaranta, P. Virolainen, H.T. Aro, and E. Vuorio. 1994. Retarded chondrogenesis in transgenic mice with a type II collagen defect results in fracture healing abnormalities. Dev. Dyn. 200: 340-349.
120. Ho, C., D.A. Conner, M.R. Pollack, D.J. Ladd, O. Kifor, H.B. Warren, E.M. Brown, J.G. Seidman, and C.E. Seidman. 1995. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nature Genet. 11: 389-394.
121. Hofstra, R.M.W., J. Osinga, G. Tan-Sindhunata, Y. Wu, E.-J. Kamsteeg, R.P. Stulp, C. Van Ravenswaaij-Arts, D. Majoor-Krakauer, M. Angrist, A. Chakravarti, C. Meijers, and C.H.C.M. Buys. 1996. A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nature Genet. 12: 445-447.
122. Hollstein, M., D. Sidransky, B. Vogelstein, and C.C. Harris. 1991. p53 mutations in human cancers. Science 253: 49-53.
123. Hooper, M.L. 1994. The role of the p53 and Rb-1 genes in cancer, development, and apoptosis. (Suppl.) J. Cell. Sci. 18: 13-17.
124. Hope, J. 1995. Mice and beef and brain diseases. Nature 378: 761-762.
125. Horinouchi, K., S. Erlich, D.P. Perl, K. Ferlinz, C.L. Bisgaier, K. Sandhoff, R.J. Desnick, C.L. Stewart, and E.H. Schuchman. 1995. Acid sphingomyelinase deficient mice: A model of types A and B Niemann-Pick disease. Nature Genet. 10: 288-293.
126. Hosoda, K., R.E. Hammer, J.A. Richardson, A.G. Baynash, J.C. Cheung, A. Giaid, and M. Yanagisawa. 1994. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79: 1267-1276.
127. Hsiao, K.K., D.R. Borchelt, K. Olson, R. Johannsdottir, C. Kitt, W. Yunis, S. Xu, C. Eckman, S. Younkin, D. Price, C. ladecola, H.B. Clark, and G. Carlson. 1995. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15: 1203-1218.
128. Huang, L.S., E. Voyiaziakis, D.F. Markenson, K.A. Sokol, T. Hayek, and J.L. Breslow. 1995. apoB gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes. J. Clin. Invest. 96: 2152-2161.
129. Huang, P.C., A.E. Gaitan, Y. Hao, R.M. Petters, and F. Wong. 1993. Cellular interactions implicated in the mechanism of photoreceptor degeneration in transgenic mice expressing a mutant rhodopsin gene. Proc. Natl. Acad. Sci. 90: 8484-8488.
130. Huang, X.Z., J.F. Wu, D. Cass, D.J. Erie, D. Corry, S.G. Young, R.V. Farese, Jr., and D. Sheppard. 1996. Inactivation of the integrin β6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lungs and skin. J. Cell. Biol. 133: 921-928.
131. Hui, C.-C. and A.L. Joyner. 1993. A mouse model of Greig cephalopolysyndactyly syndrome: The extra-toes 1 mutation contains an intragenic deletion of the Gli3 gene. Nature Genet. 3: 241-246.
132. Huizinga, J.D., L. Thuneberg, M. Klüppel, J. Malysz, H.B. Mikkelsen, and A. Bernstein. 1995. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 373: 347-349.
133. Hussussian, C.J., J.P. Struewing, A.M. Goldstein, P.A.T. Higgins, D.S. Ally, M.D. Sheahan, W.H. Clark, Jr., M.A. Tucker, and N.C. Dracopoli. 1994. Germline p16 mutations in familial melanoma. Nature Genet. 8: 15-21.
134. Hyde, S.C., D.R. Gill, C.F. Higgins, A.E.O. Trezise, L.J. MacVinish, A.W. Cuthbert, R. Ratcliffe, M.J. Evans, and W.H. Colledge. 1993. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 362: 250-255.
135. Ikeda, H., M. Yamaguchi, S. Sugai, Y. Aze, S. Narumiya, and A. Kakizuka. 1996. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet. 13: 196-202.
136. Ishibashi, S., M.S. Brown, J.L. Goldstein, R.D. Gerard, R.E. Hammer, and J. Herz. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92: 883-893.
137. Ishibashi, S., J. Herz, N. Maeda, J.L. Goldstein, and M.S. Brown. 1994. The two-receptor model of lipoprotein clearance: Tests of the hypothesis in knockout mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl. Acad. Sci. 91: 4431-4435.
138. Jabs, E.W., U. Müller, X. Li, L. Ma, W. Luo, I.S. Haworth, I. Klisak, R. Sparkes, M.L. Warman, J.B. Mulliken, M.L. Snead, and R. Maxson. 1993. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75: 443-450.
139. Jacks, T. 1996. Lessons from the p53 mutant mouse. J. Cancer Res. Clin. Oncol. 122: 319-327.
140. Jacks, T., T.S. Shih, E.M. Schmitt, R.T. Bronson, A. Bernards, and R.A. Weinberg. 1994. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nature Genet. 7: 353-361.
141. Jackson, I.J. 1994. Molecular and developmental genetics of mouse coat color. Annu. Rev. Genet. 28: 189-217.
142. Jackson, I.J. and S. Raymond. 1994. Manifestations of microphthalmia. Nature Genet. 8: 209-210.
143. Jansen, G., P.J.T.A. Groenen, D. Bächner, P.H.K. Jap, M. Coerwinkel, F. Oerlemans, W. van den Broek, B. Gohlsch, D. Pette, J.J. Plomp, P.C. Molenaar, M.G.J. Nederhoff, C.J.A. van Echteld, M. Dekker, A. Berns, H. Hameister and B. Wieringa. 1996. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nature Genet. 13: 316-324.
144. Jarolim, P., H.L. Rubin, V. Brabec, and J. Palek. 1995. A nonsense mutation glu1669-to-ter within the regulatory domain of human erythroid ankyrin leads to a selective deficiency of the major ankyrin isoform (band 2.1) and a phenotype of autosomal dominant hereditary spherocytosis. J. Clin. Invest. 95: 941-947.
145. Jass, I.R., S.M. Stewart, J. Stewart, and M.R. Lane. 1994. Hereditary non-polyposis colorectal cancer: Morphologies, genes and mutations. Mutat. Res. 310: 125-133.
146. Jhiang, S.M., J.E. Sagartz, Q. Tong, J. Parker-Thornburg, C.C. Capen, J.-Y. Cho, S. Xing, and C. Ledent. 1996. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137: 375-378.
147. Justice, M.J., C.M. Silan, J.D. Ceci, A.M. Buchberg, N.G. Copeland, and N.A. Jenkins. 1990. A molecular genetic linkage map of mouse chromosome 13 anchored by the beige (bg) and satin (sa) loci. Genomics 6: 341-350.
148. Kappas, A., S. Sassa, R.A. Galbraith, and Y. Nordmann. 1995. The porphyrias. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 2103-2159. McGraw-Hill, New York, NY.
149. Kapur, R.P., D.A. Sweetser, B. Doggett, J.R. Siebert, and R.D. Palmiter. 1995. Intercellular signals downstream of endothelin receptor-B mediate colonization of the large intestine by enteric neuroblasts. Development 121: 3787-3795.
150. Kawaguchi, Y., T. Okamoto, M. Taniwaki, M. Aizawa, M. Inoue, S. Katayama, H. Kawakami, S. Nakamura, M. Nishimura, I. Akiguchi, J. Kimura, S. Narumiya, and A. Kakizuka. 1994. CAG expansions in a novel gene for Machado-foseph disease at chromosome 14q32.1. Nature Genet. 8: 221-228.
151. Kazazian, H.H., Jr., E.G.D. Tuddenham, and S.E. Antonarakis. 1995. Haemophilia A and parahaemophilia: Deficiencies of factors VIII and V. In The metabolic, and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 3241-3267. McGraw-Hill, New York, NY.
152. Keller, S.A., J.M. Jones, A. Boyle, L.L. Barrow, P.D. Killen, D.G. Green, N.V. Kapousta, P.P. Hitchcock, R.T. Swank, and M.H. Meisler. 1994. Kidney and retinal defects (Krd), a transgene-induced mutation with A deletion of mouse chromosome 19 that includes the Pax2 locus. Genomics 23: 309-320.
153. Kelly, E.J. and R.D. Palmiter. 1996. A murine model of Menkes disease reveals a physiological function of metallothionein. Nature Genet. 13: 219-222.
154. Klehig, M.L., L.B. Russell, and E.M. Rinchik. 1992. Munne fumarylacetoacetate hydrolase (Fah) gene is disrupted by a neonatally lethal albino deletion that defines the hepatocyte-specific developmental regulation 1 (hsdr-1) locus. Proc. Natl. Acad. Sci. 89: 1363-1367.
155. Knecht, T.P. and C.K. Glass. 1995. The influence of molecular biology on our understanding of lipoprotein metabolism and the pathobiology of atherosclerosis. Adv. Genet. 32: 141-199.
156. Knudson, A.G. 1988. Hereditary cancers disclose a class of cancer genes. Cancer 63: 1888-1891.
157. Kreidberg, J.A., H. Sariola, J.M. Loring, M. Maeda, J. Pelletier, D. Housman, and R. Jaenisch. 1993. WT-1 is required for early kidney development. Cell 74: 679-691.
158. LaFerla, P.M., B.T. Tinkle, C.J. Bieberich, C.C. Haudenschild, and G. Jay. 1995. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genet. 9: 21-30.
159. LaSpada, A.R., E.M. Wilson, D.B. Lubahn, A.E. Harding, and K.H. Fischbeck. 1991. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352: 77-79.
160. Lavigueur, A., V. Maltby, D. Mock, J. Rossant, T. Pawson, and A. Bernstein. 1989. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol. Cell. Biol. 9: 3982-3991.
161. Leach, F.S., N.C. Nicolaides, N. Papadopoulos, B. Liu, J. Jen, R. Parsons, P. Peltomäki, P. Sistonen, L.A. Aaltonen, M, Nyström-Lahti, X.-Y. Guan, J. Zhang, P.S. Meltzer, J.-W. Yu, F.-T. Kao, D.J. Chen, K.M. Cerosaletti, R.E.K. Fournier, S. Todd, T. Lewis, R.J. Leach, S.L. Naylor, J. Weissenbach, J.-P. Mecklin, H. Järvinen, G.M. Petersen, S.R. Hamilton, J. Green, J. Jass, P. Watson, H.T. Lynch, J.M. Trent, A. de la Chapelle, K.W. Kinzler, and B. Vogelstein. 1993. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215-1225.
162. Lei, K.J., H. Chen, C.J. Pan, J.M. Ward, B. Mosinger, Jr., E.J. Lee, H. Westphal, B.C. Mansfield, and J.Y. Chou. 1996. Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1 a mouse. Nature Genet. 13: 203-209.
163. c. Immunol. Rev. 138: 61-86.
164. Levine, A.J., J. Momand, and C.A. Finlay. 1991. The p53 tumour suppressor gene. Nature 351: 453-456.
165. Levinson, B., C. Vulpe, B. Elder, C. Martin, F. Verley, S. Packman, and J. Gitschier. 1994. The mottled gene is the mouse homologue of the Menkes disease gene. Nature Genet. 6: 369-373.
166. Li, S.-W., D.J. Prockop, H. Helminen, R. Fässler, T. Lapveteläinen, K. Kiraly, A. Peltarri, J. Arokoski, H. Lui, M. Arita, and J.S. Khillan. 1995a. Transgenic mice with targeted inactivation of the Col2a1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes & Dev. 9: 2821-2830.
167. Li, T. and B.L. Davidson. 1995. Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. 92: 7700-7704.
168. Li, Y., D.A. Lacerda, M.L. Warman, D.R. Beier, H. Yoshioka, Y. Ninomiya, J.T. Oxford, N.P. Morris, K. Andrikopoulos, F. Ramirez, B.B. Wardell, G.D. Lifferth, C. Teuscher, S.R. Woodward, B.A. Taylor, R.E. Seegmiller, and B.R. Olsen. 1995b. A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. Cell 80: 423-430.
169. Lin, S.-C., C.R. Lin, I. Gukovsky, A.J. Lusis, P.E. Sawchenko, and M.G. Rosenfeld. 1993. Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature 364: 208-213.
170. Lindberg, R.L.P., C. Porcher, B. Grandchamp, B. Ledermann, K. Bürki, S. Brandner, A. Aguzzi, and U.A. Meyer. 1996. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nature Genet. 12: 195-198.
171. Linton, M.F., J.B. Atkinson, and S. Fazio. 1995. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 267: 1034-1037.
172. Liu, X., H. Wu, M. Byrne, I. Jeffrey, S. Krane, and R. Jaenisch. 1995a. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J. Cell. Biol. 130: 227-237.
173. Liu, Y.H., R. Kundu, L. Wu, W. Luo, M.A. Ignelzi, Jr., M.L. Snead, and R.E. Maxson, Jr. 1995h. Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. Proc. Natl. Acad. Sci. 92: 6137-6141.
174. Lledo, P.-M., P. Tremblay, S.J. DeArmond, S.B. Prusiner, and R.A. Nicoll. 1996. Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc. Natl. Acad. Sci. 93: 2403-2407.
175. Lloyd, C., Q.C. Yu, J. Cheng, K. Turksen, L. Degenstein, E. Hutton, and E. Fuchs. 1995. The basal keratin network of stratified squamous epitheha: Defining K15 function in the absence of K14. J. Cell. Biol. 129: 1329-1344.
176. Longo, G., R. Strinati, F. Poli, and F. Fumi. 1987. Genetic factors in nonspecific bronchial hyperreactivity. An epidemiologic study. Am. J. Dis. Child. 141: 331-334.
177. Ma, J., J.C. Norton, A.C. Allen, J.B. Burns, K.W. Hasel, J.L. Burns, J.G. Sutcliffe, and G.H. Travis. 1995. Retinal degenration slow (rds] in mouse results from simple insertion of a t haplotype-specific element into protein-coding exon II. Genomics 28: 212-219.
178. McInnes, R.R. and R.A. Bascom. 1992. Retinal genetics: A nullifying effect for rhodopsin. Nature Genet. 1: 155-157.
179. McKusick, V.A., C.A. Francomano, S.E. Antonarakis, and P.L. Pearson. 1994. Mendelian inheritance in man. A catalog of human genes and genetic disorders, 11th edition. Johns Hopkins University Press, Baltimore, MD.
180. McLaughlin, M.E., M.A. Sandberg, E.L. Berson, and T.P. Dryja. 1993. Recessive mutations in the gene encoding the β-subunit of rod phosphodiesterase in patients with retinitis pigmentosa. Nature Genet. 4: 130-133.
181. McLaughlin, M.E., T.L. Ehrhart, E.L. Berson, and T.P. Dryja. 1995. Mutation spectrum of the gene encoding the β-subunit of rod phosphodiesterase among patients with autosomal recessive retinitis pigmentosa. Proc. Natl. Acad. Sci. 92: 3249-3253.
182. MacLennan, D.H. and M.S. Phillips. 1992. Malignant hyperthermia. Science 256: 789-794.
183. Min-induced intestinal neoplasia. Cell 81: 957-966.
184. Mahley, R.W. and S.C. Rail, Jr. 1995. Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 1953-1980. McGraw-Hill, New York, NY.
185. Malkin, D. 1994. Germline p53 mutations and heritable cancer. Annu. Rev. Genet. 28: 443-465.
186. Marchioli, R., R.M. Marfisi, F. Carinci, and G. Tognoni. 1996. Meta-analysis, clinical trials, and transferability of research results into practice: The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease Arch. Intern. Med. 156: 1158-1172.
187. Maréchal, V., N. Naffakh, O. Danos, and J.M. Heard. 1993. Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow cells. Blood 82: 1358-1365.
188. Markert, M.L. 1994. Molecular basis of adenosine deaminase deficiency. Immunodeficiency 5: 141-157.
189. Martini, R., J. Zielasek, K.V. Toyka, K.P. Giese, and M. Schachner. 1995. Protein zero (PO)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nature Genet. 11: 281-286.
190. Masliah, E., M. Mallory, N. Ge, M. Alford, I. Veinbergs, and A.D. Roses. 1995. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136: 107-121.
191. Massague, J. 1996. Crossing receptor boundaries. Nature 382: 29-30.
192. Masters, B.A., E.J. Kelly, C.J. Quaife, R.L. Brinster, and R.D. Palmiter. 1994. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl. Acad. Sci. 91: 584-588.
193. Megeney, L.A., B. Kahlar, K. Garrett, J.E. Anderson, and M.A. Rudnicki. 1996. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes &. Dev. 10: 1173-1183.
194. Melo, J.A., J. Shendure, K. Pociask, and L.M. Silver. 1996. Identification of sex-specific quantitative trait loci controlling alcohol preference in C57BL/6 mice. Nature Genet. 13: 147-153.
195. Mercer, J.F.B., A. Grimes, L. Ambrosini, P. Lockhart, J.A. Paynter, H. Dierick, and T.W. Glover. 1994. Mutations in the murine homologue of the Menkes gene in dappled and blotchy mice. Nature Genet. 6: 374-378.
196. Migchielsen, A.A.J., M.L. Breuer, M.A. van Roon, H. te Riele, C. Zurcher, F. Ossendorp, S. Toutain, M.S. Hershfield, A. Berns, and D. Valerio. 1995. Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death. Nature Genet. 10: 279-287.
197. Mitchell, G.A., M. Lambert, and R.M. Tanguay. 1995. Hypertyrosinemia. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 1077-1106. McGraw-Hill, New York, NY.
198. Mombaerts, P., J. Iacomim, R.S. Johnson, K. Herrup, S. Tonegawa, and V.E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
199. Monaco, A.P. and J. Chelly. 1995. Menkes and Wilson diseases. Adv. Genet. 33: 233-253.
200. Moore, K.J. 1995. Insight into the microphthalmia gene. Trends Genet. 11: 442-448.
201. Moran, P.M., L.S. Higgins, B. Cordell, and P.C. Moser. 1995. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human β-amyloid precursor protein. Proc. Natl. Acad. Sci. 92: 5341-5345.
202. Min: A mouse model for intestinal and mammary tumorigenesis. Eur. J. Cancer 31A: 1061-1064.
203. Moullier, P., D. Bohl, J.-M. Heard, and O. Danos. 1993. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts. Nature Genet. 4: 154-159.
204. Mueller, R.F. 1994. The Denys-Drash syndrome, J. Med. Genet. 31: 471-477.
205. Muenke, M. and U. Schell. 1995. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet. 11: 308-313.
206. Müller, U., N. Cristina, Z.-W. Li, D.P. Wolfer, H.-P. Lipp, T. Rülicke, S. Brandner, A. Aguzzi, and C. Weissmann. 1994. Behavioral and anatomical deficits in mice homozygous for a modified β-amyloid precursor protein gene. Cell 79: 755-765.
207. Mulligan, L.M., J.B.J. Kwok, C.S. Healey, M.J. Elsdon, C. Eng, E. Gardner, D.R. Love, S.E. Mole, J.K. Moore, L. Papi, M.A. Ponder, H. Telenius, A. Tunnacliffe, and B.A.J. Ponder. 1993. Germ-line mutations of the RET proto-oncogene of multiple endocrine neoplasia type 2A. Nature 363: 458-460.
208. Muragaki, Y., E.C.M. Mariman, S.E.C. van Beersum, M. Perälä, J.B.A. van Mourik, M.L. Warman, B.R. Olsen, and B.C.J. Hamel. 1996a. A mutation in the gene encoding the α2 chain of the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2). Nature Genet. 12: 103-105.
209. Muragaki, Y., S. Mundlos, J. Upton, and B.R. Olsen. 1996b. Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science 272: 548-551.
210. Naash, M.I, J.G. Hollyfield, M.R. Al-Ubaidi, and W. Baehr. 1993. Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene. Proc. Natl Acad. Sci. 90: 5499-5503.
211. Naash, M.L, N.S. Peachey, Z.-Y. Li, C.C. Gryczan, Y. Goto, J. Blanks, A.H. Milam, and H. Ripps. 1996. Light-induced acceleration of photoreceptor degeneration in transgenic mice expressing mutant rhodopsin. Invest. Ophthalmol. &. Visual Sci. 37: 775-782.
212. Nagase, H., S. Bryson, H. Cordell, C.J. Kemp, F. Fee, and A. Balmain. 1995. Distinct genetic loci control development of benign and malignant skin tumours in mice. Nature Genet. 10: 424-429.
213. Nakata, K., K. Ono, J. -I. Miyazaki, B.R. Olsen, Y. Muragaki, E. Adachi, K.-I. Yamamura, and T. Kimura. 1993. Osteoarthritis associated with mild chondrodysplasia in transgenic mice expressing α1(IX) collagen chains with a central deletion. Proc. Natl. Acad. Sci. 90: 2870-2874.
214. Nasir, J., S.B. Floresco, J.R. O'Kusky, V.M. Diewert, J.M. Richman, J. Zeisler, A. Borowski, J.D. Marth, A.G. Phillips, and M.R. Hayden. 1995. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81: 811-823.
215. Naski, M.C., Q. Wang, J. Xu, and D.M. Ornitz. 1996. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nature Genet. 13: 233-237.
216. Nawrotzki, R., D.J. Blake, and K.E. Davies. 1996. The genetic basis of neuromuscular disorders. Trends Genet. 12: 294-298.
217. Neuteld, E.F. and J. Muenzer. 1995. The mucopolysaccharidoses. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 2465-2494, McGraw-Hill, New York, NY.
218. Nicolaides, N.C., N. Papadopoulos, B. Liu, Y.-F. Wei, K.C. Carter, S.M. Ruhen, C.A. Rosen, W.A. Haseltine, R.D. Fleischmann, C.M. Fraser, M.D. Adams, J.C. Venter, M.G. Dunlop, S.R. Hamilton, G.M. Petersen, A. de la Chapelle, B. Vogelstein, and K.W. Kinzler. 1994. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature: 371: 75-80.
219. Nigro, I.M., S.J. Baker, A.C. Preisinger, J.M. Jessup, R. Hostetter, K. Cleary, S.H. Bigner, N. Davidson, S. Baylin, P. Devilee, T. Glover, F.S. Collins, A. Weston, R. Modali, R, C.C. Harris, and B. Vogelstein. 1989. Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708.
220. Olsen, B.R. 1995. Mutations in collagen genes resulting in metaphyseal and epiphyseal dysplasias. Bone 17: 45S-49S.
221. Oostra, B.A. and P.J. Willems. 1995. A fragile gene. BioEssays 17: 941-947.
222. Otterbach, B. and W. Stoffel. 1995. Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). Cell 81: 1053-1061.
223. Overturf, K., M. Al-Dhalimy, R. Tanguay, M. Brantly, C.-N. Ou, M. Finegold, and M. Grompe. 1996. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nature Genet. 12: 266-273.
224. Paigen, B., A.S. Plump, and E.M. Rubin. 1994. The mouse as a model for human cardiovascular disease and hyperlipidemia. Curr. Opin. Lipidol. 5: 258-264.
225. Pászty, C., N. Mohandas, M.E. Stevens, J.F. Loring, S.A. Liebhaber, C.M. Brion, and E.M. Rubin. 1995. Lethal α-thalassaemia created by gene targeting in mice and its genetic rescue. Nature Genet. 11: 33-39.
226. Pavan, W.J., S. Mac, M. Cheng, and S.M. Tilghman. 1995. Quantitative trait loci that modify the severity of spotting in piebald mice. Genome Res. 5: 29-41.
227. Peifer, M. 1996. Regulating cell proliferation: As easy as APC. Science 272: 974-975.
228. Pericak-Vance, M.A. and J.L. Haines. 1995. Genetic susceptibility to Alzheimer disease. Trends Genet. 11: 504-508.
229. Perou, C.M. and J. Kaplan. 1993. Complementation analysis of Chediak-Higashi syndrome: The same gene may be responsible for the defect in all patients and species. Somatic Cell Mol. Genet. 19: 459-468.
230. Perou, C.M., K.J. Moore, D.L. Nagle, D.J. Misumi, E.A. Woolf, S.H. McGrail, L. Holmgren, T.H. Brody, B.J. Dussault, Jr., C.A. Monroe, G.M. Duyk, R.J. Pryor, L. Li, M.J, Justice, and J. Kaplan. 1996. Identification of the murine beige gene by YAC complementation and positional cloning. Nature Genet. 13: 303-308.
231. Peters, L.L., C.S. Birkenmeier, R.T. Bronson, R.A. White, S.E. Lux, E. Otto, V. Bennett, A. Higgins, and J.E. Barker. 1991. Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. J. Cell Biol. 114: 1233-1241.
232. Pittler, S.J. and W. Baehr. 1991. Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase β-subunit gene of the rd mouse. Proc. Natl. Acad. Sci. 88: 8322-8326.
233. Plump, A.S. and J.L. Breslow. 1995. Apolipoprotein E and the apolipoprotein E-deficient mouse. Annu. Rev. Nutr. 15: 495-518.
234. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75: 1297-1303.
235. Pollock, J.D., D.A. Williams, M.A. Gifford, L.L. Li, X. Du, J. Fisherman, S.H. Orkin, C.M. Doerschuk, and M.C. Dinauer. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte Superoxide production. Nature Genet. 9: 202-209.
236. Popko, B., J.F. Goodrum, T.W. Bouldin, S.H. Zhang, and N. Maeda. 1993. Nerve regeneration occurs in the absence of apolipoprotein E in mice. J. Neurochem. 60: 1155-1158.
237. Porter, R.M., S. Leitgeb, D.W. Melton, O. Swensson, R.A, Eady, and T.M. Magin. 1996. Gene targeting at the mouse cytokeratin 10 locus: Severe skin fragility and changes of cytokeratin expression in the epidermis. J. Cell Biol. 132: 925-936.
238. Prockop, D.J. and K.I. Kivirikko. 1995. Collagens: Molecular biology, diseases, and potentials for therapy. Annu. Rev. Biochem. 64: 403-434.
239. Prusiner, S.B. 1996. Prions prions prions. In Curr. Topics Microbiol and Immunol. (ed. S.B. Prusiner), vol. 207. Springer-Verlag, Berlin.
240. Ptacek, L.J., R. Tawil, R.C. Griggs, A.C. Engel, R.B. Layzer, H. Kwiccinski, P.G. McManis, L. Santiago, M. Moore, G. Fouad, P. Bradley, and M.F. Leppert. 1994. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77: 863-868.
241. Puffenberger, E.G., K. Hosoda, S.S. Washington, K. Nakao, D. DeWit, M. Yanagisawa, and A. Chakravarti. 1994. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79: 1257-1266.
242. Quinn, J.C., J.D. West, and R.E. Hill. 1996. Multiple functions for Pax6 in mouse eye and nasal development. Genes & Dev. 10: 435-446.
243. Radovick, S., M. Nations, Y. Du, L.A. Berg, B.D. Weintrauh, and F.E. Wondisford. 1992. A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 257: 1115-1118.
244. Ramesh, N., R. Fuleihan, and R. Geha. 1994. Molecular pathology of X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-I). Immunol Rev. 138: 87-104.
245. Ramirez, F. 1996. Fibrillin mutations in Marfan syndrome and related phenotypes. Curr. Opin. Genet. Dev. 6: 309-315.
246. Rawlings, D.J. and O.N. Witte. 1994. Bruton's tyrosine kinase is a key regulator in B-cell development. Immunol. Rev. 138: 105-119.
247. Reaume, A.G., T.L. Elliott, E.K. Hoffman, N.W. Kowall, R.J. Ferrante, D.F. Siwek, H.M. Wilcox, D.G. Flood, M.F. Beal, R.H. Brown, Jr., R.W. Scott, and W.D. Snider. 1996. Motor neurons in Cu/Zn Superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal iniury. Nature Genet. 13: 43-47.
248. Reddy, S., D.B.J. Smith, M.M. Rich, J.M. Leferovich, P. Reilly, B.M. Davis, K. Tran, H. Rayburn, R. Bronson, D. Cros, R.J. Balice-Gordon, and D. Housman. 1996. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nature Genet. 13: 325-335.
249. Reitmair, A.H., R. Schmits, A. Ewel, B. Bapat, M. Redston, A. Mitri, P. Waterhouse, H.-W. Mittrücker, A. Wakeham, B. Liu, A. Thomason, H. Griesser, S. Gallinger, W.G. Ballhausen, R. Fishel, and T.W. Mak. 1995. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nature Genet. 11: 64-70.
250. Renshaw, B.R., W.C. Fanslow III, R.J. Armitage, K.A. Campbell, D. Liggit, B. Wright, B.L. Davison, and C.H. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180: 1889-1900.
251. Rieux-Laucat, F., F. Le Deist, C. Hivroz, I.A.G. Roberts, K.M. Debatin, A. Fischer, and J.P. de Villartay. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347-1349.
252. Roos, D. 1994. The genetic basis of chronic granulomatous disease, Immunol. Rev. 138: 121-157.
253. Rossiter, B.J.F. and C.T. Caskey. 1995. Hypoxanthine-guanine phosphoribosyltransferase deficiency: Lesch-Nyhan syndrome and gout. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 1679-1706. McGraw-Hill, New York, NY.
254. Rozmahel, R., M. Wilschanski, A. Matin, S. Plyte, M. Oliver, W. Auerbach, A. Moore, J. Forstner, P. Durie, J. Nadeau, C. Bear, and L.-C. Tsui. 1996. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nature Genet. 12: 280-287.
255. Russell, L.B., W.L. Russell, R. A. Popp, C. Vaughan, and K.B. Jacobson. 1976. Radiation-induced mutations at mouse hemoglobin loci. Proc. Natl. Acad. Sci. 73: 2843-2846.
256. 1 subunit of the inhibitory glycine receptor in the spasmodic mouse. Nature Genet. 7: 131-135.
257. Sakaguchi, S., S. Katamine, N. Nishida, R. Moriuchi, K. Shigematsu, T. Sugimoto, A. Nakatani, Y. Kataoka, T. Houtani, S. Shirabe, H. Okada, S. Hasegawa, T. Miyamoto, and T. Noda. 1996. Loss of cerchellar Purkinje cells in aged mice homozygous for a disrupted Prp gene. Nature 380: 528-531.
258. Sands, M.S. and E.H. Birkenmeier. 1993. A single-base-pair deletion in the β-glucuronidase gene accounts for the phenotype of murine mucopolysacchandosis type VII. Proc. Natl. Acad. Sci. 90: 6567-6571.
259. Sands, M.S., C. Vogler, J.W. Kyle, J.H. Grubb, B. Levy, N. Galvin, W.S. Sly, and E.H. Birkenmeier. 1994. Enzyme replacement therapy for murine mucopolysaccharidosis Type VII. J. Clin. Invest. 93: 2324-2331.
260. Sango, K., S. Yamanaka, A. Hoffman, Y. Okuda, A. Grinberg, H. Westphal, M.P. McDonald, J.N. Crawley, K. Sandhoff, K. Suzuki, and R.L. Proia. 1995. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nature Genet. 11: 170-176.
261. Santoro, M., G. Chiappetta, A. Cerrato, D. Salvatore, L. Zhang, G. Manzo, A. Picone, G. Portella, G. Santelli, G. Vecchio, and A. Fusco. 1996. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/ PTC1 oncogene in transgenic mice. Oncogene 12: 1821-1826.
262. Sanyanusin, P., L.A. Schimmenti, L.A. McNoe, T.A. Ward, M.E.M. Pierpont, M.J. Sullivan, W.B. Dobyns, and M.R. Eccles. 1995. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nature Genet. 9: 358-364.
263. Savitsky, K., A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D.A. Tagle, S. Smith, T. Uziel, S. Sfez, M. Ashkenazi, I. Pecker, M. Frydman, R. Harnik, S.R. Patanjali, A. Simmons, G.A. Clines, A. Sartiel, R.A. Gatti, L. Chessa, O. Sanal, M.F. Lavin, N.G.J. Jaspers, A.M.R. Taylor, C.F. Arlett, T. Miki, S.M. Weissman, M. Lovett, F.S. Collins, and Y. Shiloh. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753.
264. Schedl, A., A. Ross, M. Lee, D. Engelkamp, P. Rashbass, V. van Heyningen, and N.D. Hastie. 1996. Influence of PAX6 gene dosage on development: Overexpression causes severe eye abnormalities. Cell 86: 71-82.
265. Schneider, A., J.J. Davidson, A. Wullrich, and M.W. Kilimann. 1993. Phosphorylase kinase deficiency in I-strain mice is associated with a frameshift mutation in the alpha subunit muscle isoform. Nature Genet. 5: 381-385.
266. Schuchardt, A., V. D'Agati, L. Larsson-Blomberg, F. Costantmi, and V. Pachnis. 1994. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367: 380-383.
267. Scriver, C.R., S. Kaufman, R.C. Eisensmith, and S.L.C. Woo. 1995. The hyperphenylalaninemias. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 1015-1075. McGraw-Hill, New York, NY.
268. Schwarz, K., G.H. Gauss, L. Ludwig, U. Pannicke, Z. Li, D. Linder, W. Friedrich, R.A. Seger, T.E. Hansen-Hagge, S. Desiderio, M.R. Lieber, and C.R. Bartram. 1996. RAG mutations in human B cell-negative SCID. Science 274: 97-99.
269. Serrano, M., H.W. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R.A. DePinho. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27-37.
270. Shedlovsky, A., J.D. McDonald, D. Symula, and W.F. Dove. 1993. Mouse models of human phenylketonuria. Genetics 134: 1205-1210.
271. Shehee, W.R., P. Oliver, and O. Smithies. 1993. Lethal thalassemia after insertional disruption of the mouse major adult β-globin gene. Proc. Natl Acad. Sci. 90: 3177-3181.
272. Shiang, R., S.G. Ryan, Y.-Z. Zhu, A.F. Hahn, P. O'Connell, and J.J. Wasmuth. 1993. Mutations in the a, subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nature Genet. 5: 351-357.
273. Shimada, M., S. Ishibashi, T. Inaba, H. Yagyu, K. Harada, J.I. Osuga, K. Ohashi, Y. Yazaki, and N. Yamada. 1996. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc. Natl. Acad. Sci. 93: 7242-7246.
274. Shinkai, Y., G. Rathbun, K.-P. Lam, E.M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A.M. Stall, and F.W. Alt. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
275. Sicinski, P., Y. Geng, A.S. Ryder-Cook, E.A. Barnard, M.G. Darlison, and P.J. Barnard. 1989. The molecular basis of muscular dystrophy in the mdx mouse: A point mutation. Science 244: 1578-1580.
276. Simmonds, H.A., A.S. Sahota, and K.J. Van Acker. 1995. Adenine phosphoribosyltransferase deficiency and 2,8-dihydroxyadenine urolithiasis. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 1707-1724. McGraw-Hill, New York, NY.
277. Singer, G.G., A.C. Carrera, A. Marshak-Rothstein, C. Martinez-A., and A.K. Abbas. 1994. Apoptosis, Fas and systemic autoimmunity: The MRL-1pr/1pr model. Curr. Opin. Immunol. 6: 913-920.
278. Siracusa, L.D., R. McGrath, Q. Ma, J.J. Moskow, J. Manne, P.J. Christner, A.M. Buchberg, and S.A. Jimenez. 1996. A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res. 6: 300-313.
279. Skow, L.C., B.A. Burkhart, F.M. Johnson, R.A. Popp, D.M. Popp, S.Z. Goldberg, W.F. Anderson, L.B. Barnett, and S.E. Lewis. 1983. A mouse model for β-thalassemia. Cell 34: 1043-1052.
280. Smith, J.D., E. Trogan, M. Ginsberg, C. Grigaux, J. Tian, and M. Miyata. 1995. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. 92: 8264-8268.
281. Snyder, E.Y., R.M. Taylor, and J.H. Wolfe. 1995. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374: 367-370.
282. Spritz, R.A. 1994a. Molecular basis of human piebaldism. J. Invest Dermatol. 103: 137S-140S.
283. _. 1994b. Molecular genetics of oculocutaneous albinism. Hum. Mol Genet. 3: 1469-1475.
284. Steel, K.P. 1995. Inherited hearing defects in mice. Annu. Rev. Genet. 29: 675-701.
285. Steel, K.P. and S.D.M. Brown. 1994. Genes and deafness. Trends Genet. 10: 428-435.
286. Steel, K.P. and R.J.H. Smith. 1992. Normal hearing in Splotch (Sp/+), the mouse homologue of Waardenburg syndrome type 1. Nature Genet. 2: 75-79.
287. Stem, S.A., E.L. Oates, C.R. Hall, R.M. Grumbles, L.M. Fernandez, N.A. Taylor, D. Puett, and S. Jin. 1994. Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. Mol. Endocrinol. 8: 129-138.
288. b mutation identifies a role for the HLH dimerization domain in DNA binding and provides a model for retinal degenerative disease in humans. EMBO J. 15: 6280-6289.
289. Strachan, T. and A.P. Read. 1994. PAX genes. Curr. Opin. Genet. Dev. 4: 427-438.
290. Strittmatter, W.J. and A.D. Roses. 1995. Apolipoprotein E and Alzheimer disease. Proc. Natl. Acad. Sci. 92: 4725-4727.
291. Su, L.-K., K.W. Kinzler, B. Vogelstein, A.C. Preisinger, A.R. Moser, C. Luongo, K.A. Gould, and W.F. Dove. 1992, Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670.
292. Sunada, Y., S.M. Bernier, C.A. Kozak, Y. Yamada, and K.P. Campbell. 1994. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain to dy locus. J. Biol. Chem. 269: 13729-13732.
293. Sung, C.-H., C. Makino, D. Baylor, and J. Nathans. 1994. A rhodopsin gene mutation responsible for autosomal dominant retinitis pigmentosa results in a protein that is defective in localization to the photoreceptor outer segment. J. Neurosci. 14: 5818-5833.
294. Suter, U. and G.J. Snipes. 1995. Biology and genetics of hereditary motor and sensory neuropathies. Annu. Rev. Neurosci. 18: 45-75.
295. Suzuki, K., Y. Suzuki, and K. Suzuki. 1995. Galactosylceramide lipidosis: Globoid-cell leukodystrophy (Krabbe disease). In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 2671-2692. McGraw-Hill, New York, NY.
296. Takahashi, K., J. Folmer, and P.A. Coulombe. 1994a. Increased expression of keratin 16 causes anomalies in cytoarchitecture and keratinization in transgenic mouse skin. J. Cell. Biol. 127: 505-520.
297. Takahashi, T., M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda, and S. Nagata. 1994b. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976.
298. Takeshima, H., M. lino, H. Takekura, M. Nishi, J. Kuno, O, Minowa, H. Takano, and T. Noda. 1994. Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature 369: 556-559.
299. Tassabehji, M., V.E. Newton, K. Leverton, K. Turnbull, E. Seemanova, J. Kunze, K. Sperling, T. Strachan, and A.P. Read. 1994. PAX3 gene structure and mutations: Close analogies between Wardenburg syndrome type 1 and the Splotch mouse. Hum. Mol. Genet. 3: 1069-1074.
300. Tassabehji, M., V.E. Newton, X.-Z. Liu, A. Brady, D. Donnai, M. Krajewska-Walasek, V. Murday, A. Norman, E. Obersztyn, W. Reardon, J.C. Rice, R. Trembath, P. Wieacker, M. Whiteford, R. Winter, and A.P. Read. 1995. The mutational spectrum in Waardenburg syndrome. Hum. Mol. Genet. 4: 2131-2137.
301. Telling, G.C., M. Scott, J. Mastrianni, R. Gabizon, M. Torchia, F.E. Cohen, S.J. DeArmond, and S.B. Prusiner. 1995. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular Prp with another protein. Cell 83: 79-90.
302. Telling, G.C., T. Haga, M. Torchia, P. Tremblay, S.J. DeArmond, and S.B. Prusiner. 1996. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes & Dev. 10: 1736-1750.
303. Tisch, R. and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell 85: 291-297.
304. Tobler, I., S.E. Gaus, T. Deboer, P. Achermann, M. Fischer, T. Rülicke, M. Moser, B. Oesch, P.A. McBride, and J.C. Manson. 1996. Altered circadian activity rhythms and sleep in mice devoid of priori protein. Nature 380: 639-642.
305. Toriello, H.V., T.W. Glover, K. Takahara, P.M. Byers, D.E. Miller, J.V. Higgins, and D.S. Greenspan. 1996. A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito. Nature Genet. 13: 361-365.
306. Townley, R.G., A. Bewtra, A.F. Wilson, R.J. Hopp, R.C. Nair, and G.D. Watt. 1986. Segregation analysis of bronchial response to methacholine inhalation challenge in families with and without asthma. Allergy Clin, Immunol. 77: 101-107.
307. Travis, G.H. and J.E. Hepler. 1993. A medley of retinal dystrophies. Nature Genet. 3: 191-192.
308. Travis, G.H., M.B. Brennan, P.E. Danielson, C.A. Kozak, and J.G. Sutcliffe. 1989. Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds). Nature 338: 70-73.
309. Trudel, M., N. Saadane, M.-C. Garel, J. Bardakdjian-Michau, Y. Blouquit, J.-L. Guerquin-Kern, P. Rouyer-Fessard, D. Vidaud, A. Pachnis, P.-H. Roméo, Y. Beuzard, and F. Costantini. 1991. Towards a transgenic mouse model of sickle cell disease: Hemoglobin SAD. EMBO J. 10: 3157-3165.
310. Trudel, M., M.E. De Paepe, N. Chrétien, N. Saadane, J. facmain, M. Sorette, T. Hoang, and Y. Beuzard. 1994. Sickle cell disease of transgenic SAD mice. Blood 84: 3189-3197.
311. Tsang, S.H., P. Gouras, C.K. Yamashita, H. Kjeldbye, J. Fisher, D.B. Farber, and S.P. Goff. 1996. Retinal degeneration in mice lacking the γ subunit of the rod cGMP phosphodiesterase. Science 272: 1026-1029.
312. Tu, P.-H., P. Raju, K.A. Robinson, M.E. Gurney, J.Q. Trojanowski, and V.M.-Y. Lee. 1996. Transgenic mice carrying a human mutant Superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. 93: 3155-3160.
313. Tybulewicz. V.L.J., M.L. Tremblay, M.E. LaMarca, R. Willemsen, B.K. Stubblefield, S. Winfield, B. Zablocka, E. Sidransky, B.M. Martin, S.P. Huang, K.A. Mintzer, H. Westphal, R.C. Mulligan, and E.I. Ginns. 1992. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 357: 407-410.
314. Valle, D. and O. Simell. 1995. The hyperornithinemias. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 1147-1185, McGraw-Hill, New York, NY.
315. van Doorninck, J.H., P.J. French, E. Verbeek, R.H.P.C. Peters, H. Morreau, J. Bijman, and B.J. Scholte. 1995. A mouse model for the cystic fibrosis ΔF508 mutation. EMBO J. 14: 4403-4411.
316. van Heyningen, V. 1994. One gene-Four syndromes. Nature 367: 319-320.
317. Veres, G., R.A. Gibbs, S.E. Scherer, and C.T. Caskey. 1987. The molecular basis of the sparse fur mouse mutation. Science 237: 415-417.
318. Vikkula, M., M. Metsäranta, and L. Ala-Kokko. 1994. Type II collagen mutations in rare and common cartilage diseases. Ann. Med. 26: 107-114.
319. Vikkula, M., E.C.M. Mariman, V.C.H. Lui, N.I. Zhidkova, G.E. Tiller, M.B. Goldring, S.E.C. van Beersum, M.C. de Waal Malefijt, F.H.J. van den Hoogen, H.-H. Ropers, R. Mayne, K.S.E. Cheah, B.R. Olsen, M.L. Warman, and H.G. Brunner. 1995. Autosomal dominant and recessive osteochondrodys-plasias associated with the COL11A2 locus. Cell 80: 431-437.
320. Vincent, N., T. Ragot, H. Gilgenkrantz, D. Couton, P. Chafey, A. Grégoire, P. Briand, J.-C. Kaplan, A. Kahn, and M. PerriCaudet. 1993. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet. 5: 130-134.
321. Vortkamp, A., M. Gessler, and K.-H. Grzeschik. 1991. GL13 zinc-finger gene interrupted by translocations in Greig syndrome families. Nature 352: 539-540.
322. Voss, T-W. and M.G. Rosenfeld. 1992. Anterior pituitary development: Short tales from dwarf mice. Cell 70: 527-530.
323. Vyse, T.J. and J.A. Todd. 1996. Genetic analysis of autoimmune disease. Cell 85: 311-318.
324. Wajnrajch, M.P., J.M. Gertner, M.D. Harbison, S.C. Chua, Jr., and R.L, Leibel. 1996. Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little [lit] mouse. Nature Genet. 12: 88-90.
325. Wang, T., A.M. Lawler, G. Steel, I. Sipila, A.M. Milam, and D. Valle. 1995. Mice lacking ornithine-δ-amino-transferase have paradoxical neonatal hypoornithinaemia and retinal degeneration. Nature Genet. 11: 185-190.
326. Watanabe-Fukunaga, R., C.I. Brannan, N.G. Copeland, N.A. lenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.
327. Waymire, K.G., I.D. Mahuren, J.M. Jaje, T.R. Guilarte, S.P. Coburn, and G.R. MacGregor. 1995. Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nature Genet. 11: 45-51.
328. Weatherall, D.J., J.B. Clegg, D.R. Higgs, and W.G. Wood. 1995. The hemoglobinopathies. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 3417-3484. McGraw-Hill, New York, NY.
329. Wehner, M., P.R. Clemens, A.G. Engel, and M.W. Kilimann. 1994. Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunit. Hum. Mol. Genet. 3: 1983-1987.
330. Weil, D., S. Blanchard, J. Kaplan, P. Guilford, F. Gibson, J. Walsh, P. Mburu, A. Varela, J. Levilliers, M.D. Weston, P.M. Kelley, W.J. Kimberling, M. Wagenaar, F. Levi-Acobas, D. Larget-Piet, A. Munnich, K.P. Steel, S.D.M. Brown, and C. Petit. 1995. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 374: 60-61.
331. Wells, D.J., K.E. Wells, E.A. Asante, G. Turner, Y. Sunada, K.P. Campbell, F.S. Walsh, and G. Dickson. 1995. Expression of human full-length and minidystrophin in transgenic mdx mice: Implications for gene therapy of Duchenne muscular dystrophy. Hum. Mol. Genet. 4: 1245-1250.
332. White, R.A., C.S. Birkenmeier, S.E. Lux, and J.E. Barker. 1990. Ankyrin and the hemolytic anemia mutation, nb, map to mouse chromosome 8: Presence of the nb allele is associated with a truncated ankyrin. Proc. Natl. Acad. Sci. 87: 3117-3121.
333. White, R.A., L.L. Peters, L.R. Adkison, C. Korsgren, C.M. Cohen, and S.E. Lux. 1992. The murine pallid mutation is a platelet storage pool disease associated with the protein 4.2 (pallidin) gene. Nature Genet. 2: 80-83.
334. Whitney, J.B., III and E.S. Russell. 1980. Linkage of genes for adult α-globin and embryonic α-like globin chains. Proc. Natl. Acad. Sci. 77: 1087-1090.
335. Wicker, L.S., J.A. Todd, and L.B. Peterson. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol 13: 179-200.
336. Williamson, D.J., M.L. Hooper, and D.W. Melton. 1992. Mouse models of hypoxanthine phosphoribosyltransferase deficiency. J. Inherit. Metab. Dis. 15: 665-673.
337. Wilson, J.M. 1996. Round two for liver gene therapy. Nature Genet. 12: 232-233.
338. Wilson, R.W., C.M. Ballantyne, C.W. Smith, C. Montgomery, A. Bradley, W.E. O'Brien, and A.L. Beaudet. 1993. Gene targeting yields a CD18-mutant mouse for study of inflammation. J. Immunol. 151: 1571-1578.
339. Wolfe, T.H., M.S. Sands, I.E. Barker, B. Gwynn, L.B. Rowe, C.A. Vogler, and E.H. Birkenmeier. 1992. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer. Nature 360: 749-753.
340. Wong, P.C., C.A. Pardo, D.R. Borchelt, M.K. Lee, N.G. Copeland, N.A. Jenkins, S.S. Sisodia, D.W. Cleveland, and D.L. Price. 1995. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14: 1105-1116.
341. Worton, D.G. and M.H. Brooke. 1995. The X-linked muscular dystrophies. In The metabolic and molecular bases of inherited disease, 7th edition (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 4195-4226. McGraw-Hill, New York, NY.
342. Wu, C.-L. and D.W. Melton. 1993. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyl-transferase-deficient mice. Nature Genet. 3: 235-240.
343. Wu, X., M. Wakamiya, S. Vaishnav, R. Geske, C. Montgomery, Jr., P. Jones, A. Bradley, and C.T. Caskey. 1994. Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc. Natl Acad. Sci. 91: 742-746.
344. Xu, H., X.-R. Wu, U.M. Wewer, and E. Engvall. 1994. Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene. Nature Genet. 8: 297-301.
345. Yamaguchi, T.P., K. Harpal, M. Henkemeyer, and J. Rossant. 1994. Fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes & Dev. 8: 3032-3044.
346. Yamanaka, S., M.D. Johnson, A. Grinberg, H. Westphal, J.N. Crawley, M. Taniike, K. Suzuki, and R.L. Proia. 1994. Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs diseases. Proc. Nad. Acad. Sci. 91: 9975-9979.
347. Young, S.G., R.V. Farese, Jr., V.R. Pierotti, S. Taylor, D.S. Grass, and M.F. Linton. 1994. Transgenic mice expressing human apoB100 and apoB48. Curr. Opin. Lipidol. 5: 94-101.
348. Zeitlin, S., J.-P. Liu, D.L. Chapman, V.E. Papaioannou, and A. Efstratiadis. 1995. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet. 11: 155-163.
349. Zheng, H., M. Jiang, M.E. Trumbauer, D.J.S. Sirinathsinghji, R. Hopkins, D.W. Smith, R.P. Heavens, G.R. Dawson, S. Boyce, M.W. Conner, K.A. Stevens, H.H. Slunt, S.S. Sisodia, H.Y. Chen, and L.H.T. Van der Ploeg. 1995. β-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81: 525-531.
350. Zhou, L., C.R. Dey, S.E. Wen, M.D. DuVall, R.A. Frizzell, and J.A. Whitsett. 1994. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science 266: 1705-1708.
351. Zhou, X.Y., H. Morreau, R. Rottier, D. Davis, E. Bonten, N. Gillemans, D. Wenger, F.G. Grosveld, P. Doherty, K. Suzuki, G.C. Grosveld, and A. d'Azzo. 1995, Mouse model for the lysosomal disorder galactosiahdosis and correction of the phenotype with overexpressing erythroid precursor cells. Genes & Dev. 9: 2623-2634.
352. Zlotogora, J., I. Lerer, S. Bar-David, Z. Ergaz, and D. Abeliovich. 1995. Homozygosity for Waardenburg syndrome. Am. J. Hum. Genet. 56: 1173-1178.
353. Zoghbi, H.Y. and H.T. Orr. 1995. Spinocerebellar ataxia type 1. Semin. Cell. Biol. 6: 29-35.